StemCell Institute Inc. (7096.T)
JPY 1286.0
(-7.28%)
JPY 1286.0
(-7.28%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 310.98 Million JPY | 57.04% |
| 2022 | 198.03 Million JPY | 48.09% |
| 2021 | 133.72 Million JPY | 114.4% |
| 2020 | 62.37 Million JPY | -77.48% |
| 2019 | 277 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 178 Million JPY | 217.86% |
| 2023 Q2 | 84.1 Million JPY | 11.12% |
| 2023 Q4 | 56 Million JPY | -41.17% |
| 2023 Q3 | 95.19 Million JPY | 13.18% |
| 2023 FY | 310.98 Million JPY | 57.04% |
| 2023 Q1 | 75.68 Million JPY | 194.05% |
| 2022 Q3 | 62.14 Million JPY | 4.38% |
| 2022 FY | 198.03 Million JPY | 48.09% |
| 2022 Q4 | 25.73 Million JPY | -58.58% |
| 2022 Q2 | 59.54 Million JPY | 0.0% |
| 2021 FY | 133.72 Million JPY | 114.4% |
| 2020 FY | 62.37 Million JPY | -77.48% |
| 2019 FY | 277 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 19.015% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | 159.019% |
| GNI Group Ltd. | 8.09 Billion JPY | 96.158% |
| Linical Co., Ltd. | 338.26 Million JPY | 8.066% |
| Trans Genic Inc. | 4.08 Million JPY | -7512.754% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 121.627% |
| Soiken Holdings Inc. | -662.2 Million JPY | 146.962% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | -125.096% |
| AnGes, Inc. | -7.43 Billion JPY | 104.181% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 124.142% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 104.323% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | -66.573% |
| NanoCarrier Co., Ltd. | -780 Million JPY | 139.869% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 126.974% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 125.722% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | 138.279% |
| RaQualia Pharma Inc. | -323.66 Million JPY | 196.082% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 125.49% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 121.868% |
| PeptiDream Inc. | 3.03 Billion JPY | 89.756% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 116.042% |
| Ribomic Inc. | -1.02 Billion JPY | 130.362% |
| SanBio Company Limited | -2.64 Billion JPY | 111.762% |
| Healios K.K. | -3.82 Billion JPY | 108.134% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 126.623% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 120.877% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 121.756% |
| StemRIM | -2.02 Billion JPY | 115.38% |
| CellSource Co., Ltd. | 923.14 Million JPY | 66.313% |
| FunPep Company Limited | -933.41 Million JPY | 133.316% |
| Kringle Pharma, Inc. | -854.15 Million JPY | 136.408% |
| Stella Pharma Corporation | -763.74 Million JPY | 140.718% |
| TMS Co., Ltd. | -960.04 Million JPY | 132.393% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 127.52% |
| Cuorips Inc. | -632.18 Million JPY | 149.192% |
| K Pharma,Inc. | 260.33 Million JPY | -19.456% |
| Takara Bio Inc. | 1.48 Billion JPY | 78.988% |
| ReproCELL Incorporated | -31.41 Million JPY | 1089.912% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | -1078.941% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | -117.213% |
| CellSeed Inc. | -846.53 Million JPY | 136.736% |